Evidence map›Paper›PMID 31433726›Full record

ReviewJournal of the American Heart Association2019

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach.

Job A J Verdonschot, Mark R Hazebroek, James S Ware, Sanjay K Prasad, Stephane R B Heymans

Abstract readReview
In one paragraph

Review in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Personalized Medicine Approach in a DCM Patient withJournal of personalized medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Job A J VerdonschotDepartment of Cardiology CARIM Maastricht University Medical Centre Maastricht The Netherlands.
Mark R HazebroekDepartment of Cardiology CARIM Maastricht University Medical Centre Maastricht The Netherlands.
James S WareCardiovascular Research Centre Royal Brompton & Harefield Hospitals NHS Trust London United Kingdom.
Sanjay K PrasadCardiovascular Research Centre Royal Brompton & Harefield Hospitals NHS Trust London United Kingdom.
Stephane R B HeymansDepartment of Cardiology CARIM Maastricht University Medical Centre Maastricht The Netherlands.

Funding

Medical Research Council MC_UP_1102/20Wellcome TrustWellcome Trust 107469/Z/15/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic TestingPrecision MedicineCardiomyopathy, DilatedCardiovascular AgentsClinical Decision-MakingGenetic Predisposition to DiseaseHumansPatient SelectionPhenotypePredictive Value of TestsRisk AssessmentRisk FactorsTreatment OutcomeCardiovascular Agentsdilated cardiomyopathypersonalizedphenotypingtherapy

Identifiers

PMID31433726
PMCPMC6585365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.